13F-HR filed by ISZO CAPITAL MANAGEMENT LP
ISZO CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 10 holding rows worth $18,812,143.
- Accession
- 0001013594-23-000495
- Filer
- CIK 1607925
- Filed
- 2023-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 10 entries on the cover page, a total value of $18,812,143 stated on the cover page (in dollars after the unit check, H1), rows summing to $18,812,143 with VALUE read as dollars as filed, 13F file number 028-16140. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LANTHEUS HLDGS INC | 516544103 | COM | 100,000 | $8,256,000 | dollars as filed | |
| CBL & ASSOC PPTYS INC | 012430878 | COMMON STOCK | 82,081 | $2,104,557 | dollars as filed | |
| NOVARTIS AG SPONSORED ADR | 66987V109 | ADR | 22,000 | $2,024,000 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 9,000 | $2,015,640 | dollars as filed | |
| INVESCO QQQ TR | 46090E103 | COM | 4,800 | $1,540,464 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 7,000 | $1,113,980 | dollars as filed | |
| SPY | 78462F103 | SHS | 2,500 | $1,023,475 | dollars as filed | |
| FIRST REPUBLIC BANK/SAN FRANCI | 33616C100 | COM | 52,000 | $727,480 | dollars as filed | |
| Amplify Energy Corp | 03212B103 | COM | 953 | $6,547 | dollars as filed | |
| GLOBAL CORD BLOOD CORP | G39342103 | COM | 279,495 | $0 | dollars as filed | Value filed as zero, left out of ratios. |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001013594-23-000495 | this filing | 2023-05-15 | acceptance time not in the bulk data set |